Ann: Q&A on the merger of QBL MCL and Medcan, page-311

I think it is unfortunate their is lot of misunderstanding around the licences - as they don't have the manufacturing licence but the cultivation and production licence which Cann group (ASX CODE CAN) also have (but to note CAN also don't have the manufacture licence as well but do also have the research licence) which is why I compared QBL to CAN from valuation perspective.

Unfortunately with a stock with lot of retail holders this leads to this sort of selling pressure imho.